Robert G. Britton

1.9k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Robert G. Britton is a scholar working on Molecular Biology, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Robert G. Britton has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Geriatrics and Gerontology. Recurrent topics in Robert G. Britton's work include Sirtuins and Resveratrol in Medicine (7 papers), Natural product bioactivities and synthesis (6 papers) and Flavonoids in Medical Research (6 papers). Robert G. Britton is often cited by papers focused on Sirtuins and Resveratrol in Medicine (7 papers), Natural product bioactivities and synthesis (6 papers) and Flavonoids in Medical Research (6 papers). Robert G. Britton collaborates with scholars based in United Kingdom, United States and Thailand. Robert G. Britton's co-authors include Karen Brown, William P. Steward, Andreas J. Gescher, Victoria Brown, Dean E. Brenner, Donald J. L. Jones, Ketan Patel, David Hemingway, Stewart Sale and Kevin West and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Cancer Research.

In The Last Decade

Robert G. Britton

27 papers receiving 1.4k citations

Hit Papers

Resveratrol for the Management of Human Health: How Far H... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert G. Britton United Kingdom 15 652 455 180 179 174 27 1.4k
Philipp Saiko Austria 22 911 1.4× 690 1.5× 268 1.5× 223 1.2× 63 0.4× 56 1.9k
Jung Ho Back United States 10 619 0.9× 516 1.1× 168 0.9× 140 0.8× 60 0.3× 10 1.2k
Alpna Tyagi United States 22 783 1.2× 177 0.4× 235 1.3× 146 0.8× 78 0.4× 31 1.4k
Bhagavathi A. Narayanan United States 22 723 1.1× 179 0.4× 152 0.8× 217 1.2× 155 0.9× 31 1.7k
Pedro Michaluart Brazil 16 708 1.1× 359 0.8× 278 1.5× 211 1.2× 45 0.3× 19 1.7k
Allan Lançon France 14 638 1.0× 603 1.3× 132 0.7× 153 0.9× 37 0.2× 18 1.3k
Faye Hsieh United States 9 707 1.1× 928 2.0× 187 1.0× 220 1.2× 72 0.4× 14 1.8k
Jeong‐Hyeon Ko South Korea 22 1.1k 1.8× 271 0.6× 475 2.6× 116 0.6× 98 0.6× 38 2.1k
Stewart Sale United Kingdom 11 469 0.7× 187 0.4× 117 0.7× 120 0.7× 235 1.4× 16 839
Brigitte Jannin France 15 801 1.2× 674 1.5× 185 1.0× 180 1.0× 45 0.3× 27 1.5k

Countries citing papers authored by Robert G. Britton

Since Specialization
Citations

This map shows the geographic impact of Robert G. Britton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Britton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Britton more than expected).

Fields of papers citing papers by Robert G. Britton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Britton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Britton. The network helps show where Robert G. Britton may publish in the future.

Co-authorship network of co-authors of Robert G. Britton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert G. Britton. A scholar is included among the top collaborators of Robert G. Britton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert G. Britton. Robert G. Britton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jones, Donald J. L., et al.. (2024). Design, preparation and biological evaluation of new Rociletinib-inspired analogs as irreversible EGFR inhibitors to treat non-small-cell-lung cancer. Bioorganic & Medicinal Chemistry. 113. 117906–117906. 2 indexed citations
3.
Brown, Karen, et al.. (2024). Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities. International Journal of Molecular Sciences. 25(2). 747–747. 75 indexed citations breakdown →
5.
Guterman, Inna, Kevin West, Hong Cai, et al.. (2022). Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells. PLoS ONE. 17(2). e0262364–e0262364. 17 indexed citations
6.
Jones, Donald J. L., Raj Kumar Singh, Peter B. Farmer, et al.. (2021). Determination of N 7‐glycidamide guanine adducts in human blood DNA following exposure to dietary acrylamide using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 36(6). e9245–e9245. 5 indexed citations
7.
Cai, Hong, Edwina N. Scott, Robert G. Britton, et al.. (2020). Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity?. American Journal of Clinical Nutrition. 113(5). 1115–1125. 13 indexed citations
8.
Guterman, Inna, et al.. (2020). The Janus-like role of proline metabolism in cancer. Cell Death Discovery. 6(1). 104–104. 91 indexed citations
9.
Howells, Lynne, et al.. (2018). An HPLC‐UV method for the simultaneous quantification of curcumin and its metabolites in plasma and lung tissue: Potential for preclinical applications. Biomedical Chromatography. 32(9). e4280–e4280. 13 indexed citations
10.
Britton, Robert G., et al.. (2015). Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol). Cancer Chemotherapy and Pharmacology. 76(1). 179–185. 9 indexed citations
11.
Britton, Robert G., et al.. (2015). Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. Annals of the New York Academy of Sciences. 1348(1). 124–133. 96 indexed citations
12.
Andreadi, Catherine, Robert G. Britton, Ketan Patel, & Karen Brown. (2014). Resveratrol-sulfates provide an intracellular reservoir for generation of parent resveratrol, which induces autophagy in cancer cells. Autophagy. 10(3). 524–525. 40 indexed citations
13.
Andreadi, Catherine, Robert G. Britton, Emma Horner‐Glister, et al.. (2013). Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence. Science Translational Medicine. 5(205). 205ra133–205ra133. 166 indexed citations
14.
Britton, Robert G., Emma Horner‐Glister, Paul R. Jenkins, et al.. (2012). Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents. European Journal of Medicinal Chemistry. 54. 952–958. 34 indexed citations
15.
Jones, Donald J. L., Emma Horner‐Glister, Ketan Patel, et al.. (2012). Tissue distribution and metabolism of the putative cancer chemopreventive agent 3′,4′,5′‐trimethoxyflavonol (TMFol) in mice. Biomedical Chromatography. 26(12). 1559–1566. 5 indexed citations
16.
Patel, Ketan, Victoria Brown, Donald J. L. Jones, et al.. (2010). Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients. Cancer Research. 70(19). 7392–7399. 477 indexed citations
18.
Britton, Robert G., Isabel Lim Fong, Karen Brown, et al.. (2009). Synthesis of the flavonoid 3′,4′,5′-trimethoxyflavonol and its determination in plasma and tissues of mice by HPLC with fluorescence detection. Journal of Chromatography B. 877(10). 939–942. 4 indexed citations
19.
Jones, Donald J. L., Robert G. Britton, Ted Ognibene, et al.. (2009). Dose-Response Relationships forN7-(2-Hydroxyethyl)Guanine Induced by Low-Dose [14C]Ethylene Oxide: Evidence for a Novel Mechanism of Endogenous Adduct Formation. Cancer Research. 69(7). 3052–3059. 30 indexed citations
20.
Jenkins, Paul R., A. James Wilson, Daniel P. G. Emmerson, et al.. (2008). Design, synthesis and biological evaluation of new tryptamine and tetrahydro-β-carboline-based selective inhibitors of CDK4. Bioorganic & Medicinal Chemistry. 16(16). 7728–7739. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026